Point-Of-Care Diagnostic Market by Products, End Users, Over the Counter & Prescription Based - Global Forecast to 2018

DUBLIN, Ireland, December 30, 1899 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/9zgp5g/pointofcare) has announced the addition of the "Point-Of-Care Diagnostic Market by Products, End Users, Over the Counter & Prescription Based - Global Forecast to 2018" report to their offering. 
     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The global point-of-care diagnostics market is dominated by North America, followed by Europe, Asia-Pacific and the Rest of the World (RoW). North America will continue to dominate the market in the forecast period, followed by the Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR of -13.6% from 2013 to 2018. 

Over the next five years, the growth of the market in the Asia-Pacific region is likely to be centered at Japan, China, and India. A number of factors such as the huge patient population base, increasing funding/investment toward the development of point of care diagnosticproducts, growing focus of both international and domestic players on the Asia-Pacific point-of-care diagnostics market, and large number of R&D activities are driving the growth of the market in the Asia-Pacific region.

A number of factors such as the rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, and decreasing number of technicians in central labs are driving the growth of the global market. Furthermore, growing government support and increasing private investments and venture funding to support new product development are other factors that are propelling the growth of the market. In addition, rising adoption of POC devices, expansion of therapeutic horizon, and technological advancements is further fueling the growth of this market.

However, a few pivotal factors such as lack of alignment with definitive central lab methods, and reluctance to change existing treatment practices are hindering the growth of this market. Moreover, disadvantages of POC testing over central lab methods and recalls of leading glucose monitoring devices are the foremost challenges faced by industry players.

New product launches is the key strategy followed by leading market players to ensure their growth in the POC diagnostics market. Moreover, partnerships, agreements, collaboration, and joint ventures; mergers and acquisitions; and expansions are some other growth strategies adopted by industry players in the global market.

Key Topics Covered: 

1. Introduction
2. Executive Summary
3. Premium Insights
4. Market Overview
5. Industry Trends
6. Point-Of-Care Diagnostics Market, By Product
7. Point-Of-Care Diagnostics Market, By Prescription Mode
8. Point-Of-Care Diagnostics Market, By End User
9. Point-Of-Care Diagnostics Market, By Geography
10. Competitive Landscape

Company Profiles: 

• Abaxis, Inc.
• Abbott Laboratories, Inc.
• Alere, Inc.
• Bayer Healthcare Ag
• Beckman Coulter, Inc.
• Becton, Dickinson And Company
• Johnson & Johnson
• Nipro Diagnostics, Inc.
• Roche Diagnostics Limited
• Siemens Healthcare

For more information visit http://www.researchandmarkets.com/research/9zgp5g/pointofcare

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets